HK55383A - Pyrimidine derivatives - Google Patents

Pyrimidine derivatives

Info

Publication number
HK55383A
HK55383A HK553/83A HK55383A HK55383A HK 55383 A HK55383 A HK 55383A HK 553/83 A HK553/83 A HK 553/83A HK 55383 A HK55383 A HK 55383A HK 55383 A HK55383 A HK 55383A
Authority
HK
Hong Kong
Prior art keywords
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Application number
HK553/83A
Inventor
Andre Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK55383(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of HK55383A publication Critical patent/HK55383A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
HK553/83A 1979-03-10 1983-11-17 Pyrimidine derivatives HK55383A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
HK55383A true HK55383A (en) 1983-11-25

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
HK553/83A HK55383A (en) 1979-03-10 1983-11-17 Pyrimidine derivatives

Country Status (24)

Country Link
JP (1) JPS55122768A (en)
AR (1) AR222691A1 (en)
AU (1) AU533547B2 (en)
BE (1) BE881752A (en)
CA (1) CA1132561A (en)
CH (1) CH644368A5 (en)
DE (3) DE3009071C2 (en)
EG (1) EG14282A (en)
FI (1) FI66357C (en)
FR (2) FR2451370A1 (en)
GB (1) GB2045756B (en)
HK (1) HK55383A (en)
IE (1) IE49547B1 (en)
IN (1) IN153791B (en)
LU (1) LU82185A1 (en)
MX (1) MX6218E (en)
MY (1) MY8400200A (en)
NL (1) NL184833C (en)
NO (1) NO154054C (en)
NZ (1) NZ192927A (en)
OA (1) OA06484A (en)
PT (1) PT70882A (en)
SE (1) SE435180B (en)
SG (1) SG22683G (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (en) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic NEW ISOPROPYLAMINO PYRIMIDINE DERIVATIVE, ITS PREPARATION AND THERAPEUTIC COMPOSITION BASED ON ITS COMPOUNDS
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
FR2451370B1 (en) 1983-05-13
FI66357C (en) 1984-10-10
DE3009071A1 (en) 1980-09-11
LU82185A1 (en) 1980-06-06
DE3016752A1 (en) 1980-12-04
GB2045756B (en) 1983-01-26
MY8400200A (en) 1984-12-31
DE3009071C2 (en) 1985-11-14
GB2045756A (en) 1980-11-05
NL8001289A (en) 1980-09-12
JPS55122768A (en) 1980-09-20
MX6218E (en) 1984-12-21
IN153791B (en) 1984-08-18
CA1132561A (en) 1982-09-28
SG22683G (en) 1983-12-16
IE800477L (en) 1980-09-10
NL184833C (en) 1989-11-16
NL184468B (en) 1989-03-01
DE3050999C2 (en) 1986-08-14
IE49547B1 (en) 1985-10-30
CH644368A5 (en) 1984-07-31
JPS6126996B2 (en) 1986-06-23
NO800664L (en) 1980-09-11
EG14282A (en) 1983-09-30
FR2451191A1 (en) 1980-10-10
SE435180B (en) 1984-09-10
DE3050999A1 (en) 1985-08-14
NZ192927A (en) 1981-07-13
SE8001812L (en) 1980-09-11
BE881752A (en) 1980-05-30
NO154054C (en) 1986-07-09
FI800566A (en) 1980-09-11
FI66357B (en) 1984-06-29
AU5624880A (en) 1980-09-18
FR2451370A1 (en) 1980-10-10
NL184833B (en) 1989-06-16
AR222691A1 (en) 1981-06-15
OA06484A (en) 1981-07-31
AU533547B2 (en) 1983-12-01
FR2451191B1 (en) 1983-04-29
PT70882A (en) 1980-03-01
NO154054B (en) 1986-04-01
DE3016752C2 (en) 1987-06-25

Similar Documents

Publication Publication Date Title
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
HK55383A (en) Pyrimidine derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
CU35300A (en) Pyrrholidine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2065111B (en) Decaprenylamine derivatives
HK55583A (en) Pyrimidine derivatives
GB2053899B (en) Terahydrophthalamide derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
HK55483A (en) Isopropylamino-pyrimidine derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
JPS55104270A (en) Novel pyrimidine derivative
GB2059954B (en) 1-phenethylimidazole derivatives
GB2043064B (en) Oximidazoquinoxaline derivatives
JPS55145683A (en) Pyrimidone derivative
GB2065110B (en) Decaprenylamine derivatives
GB2042508B (en) 3-alkoxy-penem derivatives
GB2065109B (en) Decaprenylamine derivatives
IL57063A0 (en) Pyrimidone derivatives
PH15109A (en) Pyrimidone derivatives